Trial Profile
A study evaluating safety of inflammatory bowel disease patients receiving vedolizumab perioperatively.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary) ; Infliximab
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 06 Jan 2017 New trial record